Acetylcysteine inhalation to prevent pneumonia in ventilated patients
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests if breathing in a medication called acetylcysteine can help prevent lung infections in patients who are on a breathing machine. If you or a loved one is on a ventilator, this treatment might reduce the chance of getting ventilator-associated pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are critically ill and on a breathing machine (ventilator).
- Doctors expect you to need the ventilator for more than 48 hours.
- Your next of kin has agreed to the study for you.
- You are not pregnant, and you do not have a current lung infection or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special method of managing the cuff of the breathing tube and suctioning below the vocal cords to prevent lung infections (pneumonia) in people who need a breathing machine for a long time. It may help reduce the risk of getting a serious lung infection while in the hospital.
This study tests whether regular suctioning of the mouth and throat can lower the chance of developing pneumonia while on a breathing machine. It may help ICU patients who need a ventilator for more than two days.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
This trial tests if N-acetylcysteine, a medicine that helps the liver and fights inflammation, can improve outcomes for adults with a severe infection and liver stress.
This trial tests whether giving an inhaled antibiotic called colistin can prevent pneumonia in patients with brain injuries who are on ventilators. If effective, it could reduce lung infections and improve recovery.
Hear when a new Ventilation Acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.